{
  "0": "ocd",
  "1": "pregnancy",
  "2": "determining drug concentration",
  "3": "chronic unpredictable mild stress in mice",
  "4": "serotinin receptor studies",
  "5": "Cytochrome P450",
  "6": "effect on fish",
  "7": "wastewater",
  "8": "In vivo pregnancy",
  "9": "Drug utilisation",
  "10": "PTSD",
  "11": "sexual dysfunction",
  "12": "fluoxetine; diverse",
  "13": "pediatric depression pharmacotneuroherapy",
  "14": "forced swimming test",
  "15": "pharmacotherapy of depression review",
  "16": "Polymorphism",
  "17": "Serotonin syndrome",
  "18": "Depression treatment in carciovascular pathologies",
  "19": "Paroxetine, diverse",
  "20": "StarD",
  "21": "Pain",
  "22": "post stroke depression",
  "23": "inflammation and serotonin",
  "24": "review of antidepressant medications",
  "25": "weight management",
  "26": "geriatric use of antidepressants",
  "27": "Brain Derived Neurotrophic Factor",
  "28": "suicide risk",
  "29": "hippocampal neurogenesis",
  "30": "fear",
  "31": "panic disorder",
  "32": "treatment response biomarker",
  "33": "bleeding risk",
  "34": "natural products",
  "35": "Anxiety",
  "36": "paroxetine binding",
  "37": "fracture risk",
  "38": "cancer",
  "39": "Dermatology",
  "40": "covid",
  "41": "alcoholism",
  "42": "irritable bowel disease",
  "43": "premature ejaculation",
  "44": "analytical chemistry",
  "45": "sleep",
  "46": "eating disorders",
  "47": "neuroimaging",
  "48": "parkinson's disease",
  "49": "drug-drug interaction",
  "50": "ssri toxicity",
  "51": "sertraline, diverse",
  "52": "bipolar disorder",
  "53": "affective effects",
  "54": "fluvoxamine",
  "55": "hot flushes (menopause)",
  "56": "diabetes",
  "57": "autoreceptors",
  "58": "neuroendocrine system",
  "59": "cocaine addiction",
  "60": "venlafaxine for depression",
  "61": "schizophrenia",
  "62": "extrapyramidal side effects",
  "63": "anxiety",
  "64": "clinical pharmacogenetics",
  "65": "synthesis and production",
  "66": "escitalopram for depression",
  "67": "epilepsy",
  "68": "pediatric drug utilisation",
  "69": "autism",
  "70": "premenstrual syndromes",
  "71": "QT prolongation",
  "72": "chronic/prolonged use",
  "73": "pharmacoeconomics/health economics",
  "74": "ion channels",
  "75": "MDMA",
  "76": "cognitive function",
  "77": "serotonin transporter",
  "78": "pulmonary hypertension",
  "79": "citalopram",
  "80": "synthesis and compounds?",
  "81": "enantiomer of citalopram",
  "82": "hyponatremia",
  "83": "geriatric depression treatment",
  "84": "sertraline diverse",
  "85": "comparative studies",
  "86": "hepatic effects",
  "87": "borderline personality disorder",
  "88": "compulsions? body dysmorphic disorder? ",
  "89": "gut microbiota",
  "90": "withdrawal symptoms",
  "91": "drug quantification (sertraline)",
  "92": "lactation",
  "93": "pediatric anxiety",
  "94": "Neurosteroids",
  "95": "astrocytic receptors",
  "96": "Neurological Disorders and Emotional Dysregulation",
  "97": "male fertility",
  "98": "vitamin supplements for depression",
  "99": "seasonal affective disorder",
  "100": "safety reviews",
  "101": "gateway to clinical trials",
  "102": "fibromyalgia",
  "103": "ssri reviews",
  "104": "marbe burying test",
  "105": "vilazodone for depression",
  "106": "depression in cancer patients",
  "107": "lipid metabolism",
  "108": "neurotrophic factors, clinical",
  "109": "Loudness Dependence of Auditory Evoked Potentials (LDAEP)",
  "110": "headache",
  "111": " stress urinary incontinence (SUI)",
  "112": "st johns worth",
  "113": "ssris",
  "114": "depression in renal disease",
  "115": "glaucoma risk",
  "116": "agomelatine for depression",
  "117": "acupuncture for depression",
  "118": "neuropsychiatric disorders",
  "119": "hypothermia",
  "120": "galanin system",
  "121": "recurrent depression",
  "122": "dysthymia",
  "123": "generic drugs",
  "124": "trichoillomania",
  "125": "addictions",
  "126": "mania risk",
  "127": "zinc and depression",
  "128": "traumatic brain injury (TBI)",
  "129": "Galactorrhea",
  "130": "Syncope",
  "131": "exercise and depression",
  "132": "sigma 1 receptor",
  "133": "critical psychiatry",
  "134": "G protein",
  "135": "hepatitis C",
  "136": "thyroid levels",
  "137": "oral cavity",
  "138": "depression in HIV",
  "139": "veterinary use",
  "140": "electric current therapy",
  "141": "olfactory bulbectomy",
  "142": "excitatory/inhibitory effects",
  "143": "multiple sclerosis",
  "144": "neurotransmitter release estimation",
  "145": "restless legs syndrome",
  "146": "chronic obstructive pulmonary disease (COPD)",
  "147": "mutism",
  "148": "tryptophan metabolism",
  "149": "Congenital myasthenic syndromes",
  "150": "reboxetine for depression",
  "151": "escitalopram, diverse",
  "152": "statins for depression",
  "153": "blood brain barrier",
  "154": "animal neuroscience",
  "155": "hormonal fluctuations",
  "156": "Gastroprotective Effects",
  "157": "too few",
  "158": "too few",
  "159": "too few",
  "160": "too few"
}
